SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating TherapeuticsMD, Inc. Buyout

May 31, 2022 1:01 PM EDT | Source: Rigrodsky Law, P.A.

Wilmington, Delaware--(Newsfile Corp. - May 31, 2022) - Rigrodsky Law, P.A. is investigating TherapeuticsMD, Inc. ("TXMD") (NASDAQ: TXMD) regarding possible breaches of fiduciary duties and other violations of law related to TXMD's agreement to be acquired by an affiliate of EW Healthcare Partners. Under the terms of the agreement TXMD's shareholders will receive $10.00 in cash for each share of TXMD common stock they own.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-therapeuticsmd-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/125989

info